Calls and Coordination for Transitions of Care at Re-entry
NCT ID: NCT06794983
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
488 participants
INTERVENTIONAL
2025-09-19
2028-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Will there be more non-emergency, outpatient clinic visits?
Researchers will compare the number of clinic visits between people who use a Nurse Case Manager (NCM) to people in enhanced usual care.
Participants will:
* Complete surveys
* Talk to a study team member 2-3 times, or talk to a study team member 2-3 times and talk to an NCM 6-11 times
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
NCT02926482
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
NCT05286879
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
NCT06116266
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support
NCT04309565
Treatment Navigation for Opioid Use Disorder
NCT03398265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phone Group
Participants will receive phone calls and texts.
In-person visit with study team member
Participants meet with a study team member before they are released from prison.
Phone calls and texts
Study team member calls and texts participants after they are released from prison.
Phone + Nurse Case Manager (NCM) Group
Participants will work with a nurse case manager, who will call and text.
In-person visit with NCM
Participants meet with a NCM before they are released from prison.
Phone calls and texts - NCM
Nurse case manager calls and texts participants after they are released from prison.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-person visit with study team member
Participants meet with a study team member before they are released from prison.
In-person visit with NCM
Participants meet with a NCM before they are released from prison.
Phone calls and texts
Study team member calls and texts participants after they are released from prison.
Phone calls and texts - NCM
Nurse case manager calls and texts participants after they are released from prison.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* eligibility for WI Medicaid and intention to enroll before release
* substance use history (i.e., "have you ever considered your alcohol or drug use to be a problem?"), and
* living with, or history of, a chronic medical or psychiatric condition other than substance use disorder. This is defined as ever having been diagnosed with a medical or psychiatric chronic condition, or currently taking prescription medications for a chronic condition.
* able to read, understand, and speak English.
Exclusion Criteria
* no substance use history
* not living with, or no history of, chronic medical or psychiatric condition
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marguerite Burns
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A538500
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version 11/8/2024
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/POP HEALTH SCI/POP HLTH
Identifier Type: OTHER
Identifier Source: secondary_id
2024-1669
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.